ISRCTN39498786已完成不适用
A comparison of hybrid chemotherapy versus hybrid chemotherapy and autotransplant in poor prognosis Hodgkin's disease
K Co-ordinating Committee for Cancer Research (UKCCCR)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histological diagnosis of Hodgkin's disease
- •2. Prognostic index of at least 0.5
- •3. Aged under 60
- •4. No prior chemotherapy or radiotherapy
- •5. No known significant heart, lung or renal disease
- •6. No co-existing malignancies apart from localised skin lesions
排除标准
- •Not provided at time of registration
研究者
相似试验
未知
1 期
Clinical evaluation of NK211 and CDDP for cervical cancer.Advanced and/or recurrent cervical cancer.JPRN-jRCT2080221794ippon Kayaku Co., Ltd.
已完成
3 期
A phase III randomized study with Paclitaxel (Taxol) and Gemcitabine or Vinorelbine in patients with stage IIIBw - IV non-operable non-small cell lung cancer (NSCLC), performance status (PS) 0,1.on-Small Cell Lung CancerCancer - Lung - Non small cellNon-Small Cell Lung CancerACTRN12609000946213Hellenic Cooperative Oncology Group441
已完成
不适用
Efficacy and safety of hybrid therapy combined with branched-chain amino acid and resistance training in frail patients with cardiovascular diseasefrail patients with cardiovascular diseaseJPRN-UMIN000034714Sakakibara Heart Institute90
已完成
不适用
Efficacy and safety of hybrid therapy combined with branched-chain amino acid and resistance training in frail CKD patients with cardiovascular diseasefrail CKD patients with cardiovascular diseaseJPRN-UMIN000034733Department of Rehabilitation, Sakakibara Heart institute90
未知
2 期
A phase II study of combination chemotherapy of oral tegafur/uracil, leucovorin and bevacizumab for patients not appropriate for intensive therapy with unresectable or recurrent colorectal cancerunresectable metastatic/recurrent colorectal cancerJPRN-UMIN000024330Dept of Surgical Oncology Osaka City University Graduate School of Medicine35